Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.097 AUD | +2.11% | -2.02% | -11.82% |
May. 06 | IDT Australia Secures Victorian Government Funding for Cancer Medication Production Facility | MT |
Apr. 16 | IDT Australia Signs Master Service Agreement with Sanofi | MT |
Sales 2022 | 12.13M 8.01M | Sales 2023 | 7.03M 4.64M | Capitalization | 23.76M 15.69M |
---|---|---|---|---|---|
Net income 2022 | -1M -660K | Net income 2023 | -8M -5.28M | EV / Sales 2022 | 1.6 x |
Net cash position 2022 | 8.33M 5.5M | Net cash position 2023 | 3.69M 2.44M | EV / Sales 2023 | 2.85 x |
P/E ratio 2022 |
-23
x | P/E ratio 2023 |
-1.87
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.18% |
1 day | +2.11% | ||
1 week | -2.02% | ||
Current month | +2.11% | ||
1 month | +8.99% | ||
3 months | +1.04% | ||
6 months | +16.87% | ||
Current year | -11.82% |
Managers | Title | Age | Since |
---|---|---|---|
Paul McDonald
CEO | Chief Executive Officer | - | 20-12-31 |
Director of Finance/CFO | - | 22-09-27 | |
Kagiaros Chris
HRO | Human Resources Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
CHM | Chairman | 54 | 22-10-09 |
Geoffrey Sam
BRD | Director/Board Member | - | 22-10-09 |
Jane Ryan
BRD | Director/Board Member | 65 | 22-01-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.097 | +2.11% | 80 455 |
24-05-10 | 0.095 | -2.06% | 38,083 |
24-05-09 | 0.097 | -1.02% | 121,070 |
24-05-08 | 0.098 | +2.08% | 314,888 |
24-05-07 | 0.096 | -3.03% | 113,000 |
Delayed Quote Australian S.E., May 13, 2024 at 01:39 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-11.82% | 22.05M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.03% | 22.25B | |
-13.14% | 22.09B | |
-8.07% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- IDT Stock